GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » Sale Of Investment

China Resources Pharmaceutical Group (HKSE:03320) Sale Of Investment : HK$29,889 Mil (TTM As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Sale Of Investment?

China Resources Pharmaceutical Group's sale of investment for the six months ended in Jun. 2024 was HK$15,824 Mil. It means China Resources Pharmaceutical Group gained HK$15,824 Mil from selling investments. China Resources Pharmaceutical Group's sale of investment for the trailing twelve months (TTM) ended in Jun. 2024 was HK$29,889 Mil.

Compared with last quarter (HK$14,064 Mil in Dec. 2023 ), China Resources Pharmaceutical Group gained more money from selling investments in Jun. 2024 (HK$15,824 Mil).


China Resources Pharmaceutical Group Sale Of Investment Historical Data

The historical data trend for China Resources Pharmaceutical Group's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Sale Of Investment Chart

China Resources Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39,003.35 35,574.52 25,132.76 31,082.39 24,451.92

China Resources Pharmaceutical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,284.02 16,521.81 10,387.83 14,064.10 15,824.43

China Resources Pharmaceutical Group Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$29,889 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Resources Pharmaceutical Group Sale Of Investment Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG
China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2023, the medical distribution business accounts for 82.6% of its total revenue. CR Pharma's manufacturing business, 17.8% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.
Executives
Bei Jing Guo You Zi Ben Yun Ying Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you

China Resources Pharmaceutical Group Headlines

No Headlines